Longitudinal analysis of CD4 T cell counts, T cell reactivity, and human immunodeficiency virus type 1 RNA levels in persons remaining AIDS-free despite CD4 cell counts <200 for >5 years

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 665-671

  Keet, I P M ^a   Janssen, M ^b   Veugelers, P J ^b   Miedema, F ^b   Klein, M R ^b   Goudsmit, J ^b   Coutinho, R A ^b   De Wolf, F ^b  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; COTRIMOXAZOLE; DIDANOSINE; PENTAMIDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RNA ANALYSIS; STRUCTURE ANALYSIS; SURVIVAL TIME;

EID: 0030854583     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514088     Document Type: Article

References (27)

1. Ho DD. Viral counts count in HIV infection. Science 1996;272:1124-5.
2. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
3. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
4. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
5. Jurriaans S, Van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994;204:223-33.
6. Goudsmit J. The role of viral diversity in HIV pathogenesis. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10(suppl 1):S15-9.
7. Daar ES, Chernyavskiy T, Zhao JQ, Krogstad P, Chen ISY, Zack JA. Sequential determination of viral load and phenotype in human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1995; 11:3-9.
8. Saag MS, Holodniy M, Kuritzkes DR, et al. HIV viral load markers in clinical practice. Nature Med 1996;2:625-9.
9. Harrigan R. Measuring viral load in the clinical setting. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10(suppl 1):S34-40.
10. Steele FR. Viral load: to treat or not to treat? Nature Med 1995;1:980.
11. Schrager LK, Young JM, Fowler MG, Mathieson BJ, Vermund SH. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994;8(suppl 1):S95-108.
12. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8: 1123-8.
13. Keet IPM, Krol A, Klein MR, et al. Characteristics of long-term asymptomatic infection with human immunodeficiency virus type 1 in men with normal and low CD4 cell counts. J Infect Dis 1994;169:1236-43.
14. Hardy AM. Characterization of long-term survivors of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1991;4:386-91.
15. 6/L but free of AIDS defining clinical disease. AIDS 1994;8:1577-83.
16. + cells and the levels of core antigens of and antibodies to the human immunodeficiency virus as predictors of AIDS among seropositive homosexual men. J Infect Dis 1988;158:615-22.
17. Van Gemen B, van Beuningen R, Nabbe A, et al. A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. J Virol Methods 1994;49:157-67.
18. Van Gemen B, Van de Wiel P, van Beuningen R, et al. The one-tube quantitative HIV-1 RNA NASBA: precision, accuracy, and application. PCR Methods Applications 1995;4:S177-84.
19. Van Gemen B, Kievits T, Nara P, et al. Qualitative and quantitative detection of HIV-1 RNA by nucleic acid sequence-based amplification. AIDS 1993;(suppl 2):S107-10.
20. Koot M, Vos AH, Keet IPM, et al. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 1992;6:49-54.
21. + cell depletion and progression to AIDS. Ann Intern Med 1993;118:681-8.
22. Van Lier RA, Boot JH, Verhoeven AJ, De Groot ER, Brouwer M, Aarden LA. Functional studies with anti-CD3 heavy chain isotype switch-variant monoclonal antibodies. J Immunol 1987;139:2873-9.
23. Schellekens PTA, Roos MTL, de Wolf F, Lange JMA, Miedema F. Low T-cell responsiveness to activation via CD3/TCR is a prognostic marker for acquired immunodeficiency syndrome (AIDS) in human immunodeficiency virus-1 infected men. J Clin Immunol 1990;10:121-7.
24. Roos MTL, Miedema F, Koot M, et al. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. J Infect Dis 1995;171:531-6.
25. Piatak M Jr, Saag MS, Yang LC, et al. Determination of plasma viral load in HIV-1 infection by quantitative competitive polymerase chain reaction. AIDS 1993;7(suppl 2):S65-71.
26. Paul DB, Kuhns MC, McNamara AL, Pottage JC Jr, Spear GT. Short-term stability of HIV provirus levels in the peripheral blood of HIV-infected individuals. J Med Virol 1995;47:292-7.
27. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-72.